Effect of Saffrons in Premenstrual Syndrome

Phase 3

• Conditions: Premenstual Syndrom.; Unspecified condition associated with female genital organs and menstrual cycle

• Registration Number: IRCT2017061233202N2
• Lead Sponsor: Vice chancellor for research, Sabzevar University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 164

Inclusion Criteria

informed consent; Eighteen to forty years; regular Menstrual Periods( 35-21 days); Normal cycle (10-3 day); Physical and Mental health; The absence of anemia in the past three months ; Having one or more Symptoms of Premenstrual Syndrome in 2 consecutive cycles; no Pregnancy intention.
Exclusion criteria: Underlying disease; Taking other drugs

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Masstalgia. Timepoint: From 14 to 28 cycles are recorded on a daily basis. Method of measurement: Vigual Scare.;Abdominal Pain. Timepoint: From 14 to 28 cycles are recorded on a daily basis. Method of measurement: Vigual Scare.;Abdominal Bloat. Timepoint: From 14 to 28 cycles are recorded on a daily basis. Method of measurement: weist size.;Deppretion. Timepoint: From 14 to 28 cycles are recorded on a daily basis. Method of measurement: Test Deppretion Beck.;Anexity. Timepoint: From 14 to 28 cycles are recorded on a daily basis. Method of measurement: Test anxiety Beck.